ArticleBiomimetics (Basel, Switzerland)2026
HCHS-Net: A Multimodal Handcrafted Feature and Metadata Framework for Interpretable Skin Lesion Classification.
Article in Biomimetics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate and timely classification of skin lesions is critical for early cancer detection, yet current deep learning approaches suffer from high computational costs, limited interpretability, and poor transparency for clinical deployment. This study presents HCHS-Net, a lightweight and interpretable multimodal framework for six-class skin lesion classification on the PAD-UFES-20 dataset. The proposed framework extracts a 116-dimensional visual feature vector through three complementary handcrafted modules: a Color Module employing multi-channel histogram analysis to capture chromatic diagnostic patterns, a Haralick Module deriving texture descriptors from the gray-level co-occurrence matrix (GLCM) that quantify surface characteristics correlated with malignancy, and a Shape Module encoding morphological properties via Hu moment invariants aligned with the clinical ABCD rule. The architectural design of HCHS-Net adopts a biomimetic approach by emulating the hierarchical information processing of the human visual system and the cognitive diagnostic workflows of expert dermatologists. Unlike conventional black-box deep learning models, this framework employs parallel processing branches that simulate the selective attention mechanisms of the human eye by focusing on biologically significant visual cues such as chromatic variance, textural entropy, and morphological asymmetry. These visual features are concatenated with a 12-dimensional clinical metadata vector encompassing patient demographics and lesion characteristics, yielding a compact 128-dimensional multimodal representation. Classification is performed through an ensemble of three gradient boosting algorithms (XGBoost, LightGBM, CatBoost) with majority voting. HCHS-Net achieves 97.76% classification accuracy with only 0.25 M parameters, outperforming deep learning baselines, including VGG-16 (94.60%), ResNet-50 (94.80%), and EfficientNet-B2 (95.16%), which require 60-97× more parameters. The framework delivers an inference time of 0.11 ms per image, enabling real-time classification on standard CPUs without GPU acceleration. Ablation analysis confirms the complementary contribution of each feature module, with metadata integration providing a 2.53% accuracy gain. The model achieves perfect melanoma and nevus recall (100%) with 99.55% specificity, maintaining reliable discrimination at safety-critical diagnostic boundaries. Comprehensive benchmarking against 13 published methods demonstrates that domain-informed handcrafted features combined with clinical metadata can match or exceed deep learning fusion approaches while offering superior interpretability and computational efficiency for point-of-care deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.